Tulane University and LSU Health Sciences Center have selected New Orleans BioInnovation Center to administer life sciences accelerator services.

Sarepta Therapeutics exercised its option to acquire Nationwide Children’s gene therapy spinout Myonexus Therapeutics after paying at least $60m for the right in May 2018.

The fund has been formed as part of a wider technology and research investment drive that will involve up to $8.3bn being spent in the next five years.

Heritage Medical Systems has backed a $25m series B round for the Caltech spinout, which is developing therapies for Parkinson’s and Autism spectrum disorder.

Heritage Medical Systems has backed the $25m series B round, which will be used to develop treatments for Parkinson’s disease and Autism spectrum disorder.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

GV and Alexandria have taken part in a $191m round to launch Maze Therapeutics with scientific co-founders from multiple universities such as Harvard and Stanford.

Sanger Institute-founded PetMedix is working on antibodies for dogs and cats based on an immune system discovery model that will adapt and extend earlier human health research.

Wisconsin Alumni Research Foundation has set up a pre-clinical drug discovery operation called Warf Therapeutics to help support biomedical projects.

Intel Capital-backed online pharmacy 1mg is in the process of raising $70m in funding, with International Finance Corporation expected to contribute.